Hermetica Superfood Encyclopedia
The Short Answer
Iron glycinate consists of ferrous iron (Fe²⁺) covalently chelated to two glycine molecules, enabling intestinal absorption via amino acid transport pathways (PepT1 and DMT1) rather than conventional mineral uptake routes, which reduces inhibition by dietary phytates, polyphenols, and calcium. A meta-analysis of 17 RCTs demonstrated that ferrous bisglycinate produced significantly higher hemoglobin levels in pregnant women (SMD 0.54 g/dL; 95% CI 0.15–0.94; P<0.01) and 64% fewer gastrointestinal adverse events compared to conventional iron salts (IRR 0.36; 95% CI 0.17–0.76; P<0.01).
CategoryMineral
GroupMineral
Evidence LevelPreliminary
Primary Keywordiron glycinate benefits
Iron Glycinate — botanical close-up
Health Benefits
**Iron Deficiency Anemia Treatment**
Ferrous bisglycinate chelate (FeBC) replenishes serum iron, hemoglobin, and ferritin stores more effectively than polymaltose or ferrous sulfate, with a double-blind RCT in children showing significant gains in hemoglobin, MCV, MCH, RDW, and ferritin after 45 days at 3 mg/kg/day.
**Superior Gastrointestinal Tolerability**
The chelate structure shields ionic iron from the GI mucosa, reducing nausea, constipation, and cramping; meta-analysis data confirm a 64% reduction in GI adverse events compared to standard iron salts, improving long-term adherence.
**Enhanced Bioavailability**
By mimicking dipeptide absorption via intestinal amino acid transporters, iron glycinate achieves higher and more consistent serum iron elevation than ferrous sulfate or ferric polymaltose, particularly in individuals with compromised digestive function or low gastric acid.
**Demand-Regulated Absorption**
Uptake scales inversely with baseline ferritin and hemoglobin levels, meaning the compound is absorbed proportionally to physiological need, reducing the risk of iron overload in replete individuals and optimizing efficacy in deficient ones.
**Hemoglobin Synthesis Support**: Glycine serves as a direct biosynthetic precursor to heme via the delta-aminolevulinic acid (ALA) pathway, meaning the glycine ligand in iron glycinate contributes dual functionality
both as a transport vehicle and as a substrate for hemoglobin production.
**Safe Use in Pregnancy**
Clinical evidence from multiple RCTs supports the use of ferrous bisglycinate in pregnant women, demonstrating superior hemoglobin response and reduced maternal GI side effects compared to ferrous sulfate, a population in which iron supplementation compliance is critical.
**Energy Metabolism and Oxygen Transport**
By restoring intracellular iron pools, iron glycinate supports iron-dependent enzymes including cytochrome c oxidase (Complex IV) and succinate dehydrogenase (Complex II), improving mitochondrial respiration and reducing fatigue associated with iron depletion.
Origin & History
Natural habitat
Iron glycinate is a synthetically manufactured chelated mineral compound, not derived from a natural botanical source. It is produced through a controlled chemical process in which ferrous iron (Fe²⁺) is reacted with glycine amino acid molecules under specific pH and temperature conditions to form a stable, fully-reacted chelate. Albion Laboratories pioneered its commercial development and holds key patents for its bisglycinate chelate form, which is manufactured globally for use in dietary supplements and functional foods.
“Iron glycinate has no history in traditional herbal or folk medicine systems, as it is a modern synthetic chelate developed in the latter half of the twentieth century. Albion Laboratories, based in Clearfield, Utah, developed and patented the bisglycinate chelate technology in the 1970s–1980s as part of a broader research program into amino acid chelated minerals, motivated by the clinical problem of poor tolerability and low bioavailability of inorganic iron salts such as ferrous sulfate. The product entered commercial supplement markets under trade names such as Ferrochel® (Albion) and has since become a gold standard reference compound in iron supplementation research. Unlike botanically sourced minerals, its development was driven entirely by pharmaceutical and nutritional science rather than cultural or ethnobotanical tradition.”Traditional Medicine
Scientific Research
The clinical evidence base for iron glycinate is moderate-to-strong, anchored by a published meta-analysis of 17 randomized controlled trials evaluating ferrous bisglycinate versus other iron forms in adults and children across at least four weeks of treatment, which quantified superior hemoglobin outcomes and dramatically reduced GI event rates. A double-blind RCT in children aged 1–13 years confirmed that 3 mg elemental iron/kg/day as ferrous bisglycinate chelate for 45 days produced significant improvements in hemoglobin, MCV, MCH, RDW, and ferritin compared to iron polymaltose complex, with no corresponding ferritin or MCH gains in the polymaltose arm. The meta-analysis subgroup in pregnant women demonstrated a standardized mean difference of 0.54 g/dL in hemoglobin (95% CI 0.15–0.94; P<0.01), a clinically meaningful effect size in a high-risk population. While the overall evidence is promising, some trials are limited by small sample sizes, variable dosing protocols, and lack of long-term follow-up beyond 12 weeks, warranting additional large-scale trials to confirm durability of effect and optimal dosing across diverse populations.
Preparation & Dosage
Traditional preparation
**Capsule/Tablet Form**
18–36 mg elemental iron per serving
The most common commercial delivery; products such as Albion Labs' Iron Glycinate™ are available in 120-count capsule formats with elemental iron content specified on label, typically .
**Therapeutic Dose (Children)**
3–6 mg elemental iron/kg body weight/day, as used in clinical trials; lower doses are sufficient relative to ferrous sulfate due to higher bioavailability
**Therapeutic Dose (Pregnant Women)**
25–60 mg elemental iron/day as ferrous bisglycinate, though clinical trials have used variable doses; prescriber guidance is recommended
Typically .
**Maintenance/Preventive Dose (Adults)**
14–18 mg elemental iron/day (RDA-aligned); iron glycinate's superior absorption means lower elemental doses may achieve equivalent or superior outcomes vs
higher-dose salts.
**Timing**
Best taken on an empty stomach or with a small meal; unlike ferrous sulfate, concurrent food intake causes less absorption reduction, offering dosing flexibility.
**Standardization**
Fully-reacted chelate (e.g., TRAACS® certified by Albion) ensures complete chelation with no free ionic iron, verified by molar ratio of two glycine molecules per iron atom.
**Liquid and Powder Forms**
Available for pediatric use; mixing with non-tannin, non-phytate beverages (water, juice) is preferred over milk or tea.
Nutritional Profile
Iron glycinate delivers elemental ferrous iron (Fe²⁺) as its primary nutritional component, with the exact elemental iron content per unit dose specified by manufacturer (commonly 18–36 mg per capsule in commercial products). The glycine ligands contribute a negligible amino acid load at supplemental doses (two glycine molecules per iron atom equates to approximately 113 mg glycine per 56 mg ferrous iron, far below physiologically meaningful glycine thresholds). No macronutrient, fat-soluble vitamin, or significant phytochemical content is present. Bioavailability is substantially higher than ferrous sulfate (relative bioavailability estimates of 1.5–2.5× depending on population and study design), with demand-regulated intestinal uptake limiting excess absorption in iron-replete individuals. The chelate remains stable across a broad pH range (2–7), preserving iron in the ferrous state through gastric transit.
How It Works
Mechanism of Action
Iron glycinate enters intestinal epithelial cells primarily through peptide transporter 1 (PepT1) and amino acid transport systems rather than exclusively through divalent metal transporter 1 (DMT1), which is the principal route for inorganic ferrous salts; this dual-pathway access reduces competition with other divalent cations such as calcium, zinc, and copper. Once absorbed, ferrous iron (Fe²⁺) is released intracellularly, where it enters the labile iron pool and is incorporated into transferrin for systemic distribution or stored as ferritin via iron regulatory protein (IRP1/IRP2) signaling. The chelate structure formed by the covalent bonds between Fe²⁺ and the two glycine carboxylate and amine groups creates a neutral, stable, lipophilic complex that resists precipitation at intestinal pH values and withstands binding by dietary inhibitors such as phytic acid, polyphenols, and phosphates. The glycine ligand is additionally incorporated into heme biosynthesis through the ALA synthase reaction in erythroid precursors, providing a substrate for porphyrin ring formation and contributing to efficient hemoglobin assembly.
Clinical Evidence
Clinical trials consistently demonstrate that ferrous bisglycinate chelate (FeBC) outperforms conventional iron forms including ferrous sulfate and ferric polymaltose in correcting iron deficiency anemia across pediatric, adult, and pregnant populations. In a pediatric RCT, FeBC at 3 mg/kg/day for 45 days significantly elevated all measured iron status markers (hemoglobin, MCV, MCH, RDW, ferritin), whereas iron polymaltose failed to improve ferritin or MCH. The meta-analysis of 17 RCTs is the most robust evidence source, showing a statistically significant hemoglobin advantage in pregnant women (SMD 0.54 g/dL) and a 64% reduction in gastrointestinal adverse event incidence (IRR 0.36; 95% CI 0.17–0.76), directly translating to better supplementation adherence. Confidence in the tolerability and short-term efficacy data is high; confidence in long-term iron repletion outcomes across all age groups remains moderate pending larger, longer-duration trials.
Safety & Interactions
At standard supplemental and therapeutic doses, iron glycinate is well tolerated, with a meta-analysis of 17 RCTs confirming a 64% reduction in gastrointestinal adverse events (nausea, constipation, epigastric discomfort) compared to ferrous salts; it is considered safe for use during pregnancy, lactation, and in pediatric populations under appropriate supervision. Drug interactions are fewer than with ionic iron salts but remain clinically relevant: iron can chelate fluoroquinolone and tetracycline antibiotics, levothyroxine, and bisphosphonates, reducing their absorption — dosing separation of at least two hours is recommended. Contraindications include hereditary hemochromatosis, hemosiderosis, hemolytic anemia with iron loading, and any condition causing pathological iron accumulation; caution is warranted in patients with inflammatory bowel disease, as luminal iron may exacerbate mucosal inflammation. The Tolerable Upper Intake Level (UL) for iron in adults is 45 mg/day elemental iron (Institute of Medicine); therapeutic doses supervised by a clinician may exceed this threshold, requiring periodic monitoring of serum ferritin and transferrin saturation to avoid toxicity.
Synergy Stack
Hermetica Formulation Heuristic
Also Known As
Ferrous bisglycinateIron bisglycinate chelateFeBCFerrochelTRAACS iron bisglycinateBis(glycinato)iron(II)
Frequently Asked Questions
Is iron glycinate better than ferrous sulfate?
Clinical evidence supports iron glycinate (ferrous bisglycinate chelate) as superior to ferrous sulfate in two key areas: tolerability and gastrointestinal side effects. A meta-analysis of 17 RCTs found 64% fewer GI adverse events with ferrous bisglycinate (IRR 0.36; 95% CI 0.17–0.76) and significantly higher hemoglobin in pregnant women (SMD 0.54 g/dL; P<0.01), making it the preferred option for individuals who experience nausea, constipation, or cramping with standard iron salts.
What is the recommended dose of iron glycinate for adults?
For adults with iron deficiency anemia, therapeutic doses of ferrous bisglycinate typically range from 25–60 mg elemental iron per day, though exact dosing should be guided by a clinician based on hemoglobin and ferritin levels. For maintenance or prophylactic supplementation, 14–18 mg elemental iron per day (in line with the adult RDA) is generally appropriate. Because iron glycinate has higher bioavailability than ferrous sulfate, lower elemental doses often achieve equivalent or superior iron repletion.
Can iron glycinate be taken with food?
Iron glycinate is more food-tolerant than conventional iron salts because its chelate structure resists binding by many common dietary inhibitors such as phytates, polyphenols, and calcium. While taking it on an empty stomach optimizes absorption, it can be taken with a light meal to improve tolerability without a major reduction in efficacy. However, it should still be separated from high-tannin beverages (tea, coffee), high-calcium foods (dairy), and zinc supplements by at least two hours to minimize any competitive absorption effects.
Is iron glycinate safe during pregnancy?
Iron glycinate is considered safe and effective during pregnancy, with multiple RCTs specifically demonstrating superior hemoglobin improvements (SMD 0.54 g/dL) and fewer gastrointestinal side effects compared to other iron forms in pregnant women. The reduced GI burden is clinically significant in pregnancy, where nausea and constipation are already common concerns that limit adherence to iron supplementation. Pregnant women should use iron glycinate under medical supervision, with doses tailored to baseline iron status and monitored with periodic ferritin and hemoglobin measurements.
Does iron glycinate cause constipation or stomach upset?
Iron glycinate causes significantly less constipation, nausea, and stomach upset than ionic iron salts such as ferrous sulfate, primarily because the chelate structure prevents free ferrous iron from directly irritating the gastrointestinal mucosa. A meta-analysis of 17 RCTs quantified this difference as a 64% reduction in gastrointestinal adverse event incidence (IRR 0.36; 95% CI 0.17–0.76) compared to other iron forms. While mild GI symptoms are still possible at higher therapeutic doses, iron glycinate is widely regarded as the most gut-friendly oral iron supplement available.
How does iron glycinate absorption compare to other iron supplement forms?
Iron glycinate (ferrous bisglycinate chelate) has superior bioavailability compared to ferrous sulfate and iron polymaltose because the glycine chelation protects the iron from binding with compounds that inhibit absorption, such as phytates and polyphenols. Clinical studies demonstrate that the chelate structure allows for more efficient intestinal uptake, resulting in better serum iron and ferritin repletion at lower doses. This enhanced absorption means patients may require smaller daily doses to achieve therapeutic benefits.
Who is iron glycinate most beneficial for?
Iron glycinate is particularly beneficial for individuals with iron deficiency anemia who experience gastrointestinal side effects from conventional iron supplements, as well as children and pregnant individuals who require effective iron replenishment with minimal digestive disturbance. It is also advantageous for people with compromised gut health or absorption issues, as the chelated form bypasses many absorption barriers. Clinical evidence shows it is especially effective in pediatric populations, where research demonstrated significant improvements in hemoglobin, ferritin, and red blood cell parameters within 45 days.
Does iron glycinate interact with common medications or supplements?
Iron glycinate can interact with certain medications and supplements, including bisphosphonates, tetracycline antibiotics, and quinolone antibiotics, which should be separated by at least 2 hours to avoid reduced absorption of either agent. Calcium supplements, antacids, and proton pump inhibitors may also reduce iron glycinate absorption when taken simultaneously. Conversely, vitamin C enhances iron glycinate absorption and can be taken together to maximize bioavailability.
Explore the Full Encyclopedia
7,400+ ingredients researched, verified, and formulated for optimal synergy.
Browse IngredientsThese statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.
hermetica-encyclopedia-canary-zzqv9k4w iron-glycinate-ferrous-bisglycinate-chelate curated by Hermetica Superfoods at ingredients.hermeticasuperfoods.com and licensed CC BY-NC-SA 4.0 (non-commercial share-alike, attribution required)
